Estimating the benefits of personalised glycaemic control

David van Klaveren; Patrick W. Serruys; David M. Kent

doi:10.1016/s0140-6736(25)01235-8

Related publications

Article2017

Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case–control study

Livia S. A. Augustin, Martina Taborelli, Maurizio Montella, Massimo Libra, Carlo La Vecchia, Alessandra Tavani, Anna Crispo, Maria Grimaldi, Gaetano Facchini, David J.A. Jenkins, Gerardo Botti, Diego Serraino, Jerry Polesel

Article2021

Glycaemic index, glycaemic load and cancer risk: results from the prospective NutriNet-Santé cohort

Charlotte Debras, Eloi Chazelas, Bernard Srour, Chantal Julia, Emmanuelle Kesse‐Guyot, Laurent Zelek, Cédric Agaësse, Nathalie Druesne‐Pecollo, Valentina A. Andreeva, Pilar Galán, Serge Hercberg, Paule Latino‐Martel, Mélanie Deschasaux, Mathilde Touvier

Article2021

Starch modification with phenolics: methods, physicochemical property alteration, and mechanisms of glycaemic control

Tao Xu, Xiaoxi Li, Shengyang Ji, Yongheng Zhong, Jesus Simal Gandara, Esra Çapanoğlu, Jianbo Xiao, Baiyi Lu

Article2018

Repurposing therapies for the personalised treatment of cystic fibrosis

Antonella Tosco, Valeria Rachela Villella, Alice Castaldo, Guido Guido Kroemer, Luigi Maiuri, Valeria Raia

Article2023

Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65

Jakub Gumprecht, Professor Gregory Lip, Adam Sokal, Beata Średniawa, Jakub Stokwiszewski, Tomasz Zdrojewski, Marcin Rutkowski, Tomasz Grodzicki, Jarosław Kaźmierczak, Grzegorz Opolski, Zbigniew Kalarus